In a similar mechanism, LINC00511 acts as a competitive endogenous RNA (ceRNA) of miR-185-3p, participating in transcriptional regulation of downstream genes and promoting proliferation of breast cancer cells and expression of stem cell factors [13]. This evidence concerns the gene LINC00511 and breast carcinoma.